Lexaria Upgrades to the OTCQX Market

Cannabis Investing News
Cannabis Investing

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has qualified and is now trading on the OTCQX Best Market, operated by OTC Markets Group. The OTCQX market is reserved for proven companies that meet stringent financial standards, provide thorough and timely news disclosure to investors, and are …

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has qualified and is now trading on the OTCQX Best Market, operated by OTC Markets Group.
The OTCQX market is reserved for proven companies that meet stringent financial standards, provide thorough and timely news disclosure to investors, and are sponsored by a qualified third-party advisor. OTCQX is recognized by the Securities and Exchange Commission as an “established public market”.
“Lexaria has made notable progress over the past twelve months in all aspects of its business, and will receive even more recognition by upgrading to OTCQX,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. “Lexaria expects to provide greater visibility and liquidity for our investors on OTCQX as we build our disruptive technology innovations through 2018 and beyond.”
Investors will find updated financial disclosure and Real-Time Level 2 quotes for LXRP at www.otcmarkets.com.
About Lexaria
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.
Click here to connect with Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) for an Investor Presentation

Source: www.thenewswire.com

The Conversation (0)
×